The noninvasive cancer diagnostics market is set to reach USD 176.24 billion in 2025, driven by the growing need for early detection and advancements in liquid biopsy, AI-powered imaging, and molecular diagnostics. With a projected market size of USD 321.41 billion by 2033 and a CAGR of 7.80%, this episode explores cutting-edge technologies revolutionizing cancer screening, biomarker discovery, and noninvasive testing to improve patient outcomes.